Zhuhai Ebang Pharmaceutical

Zhuhai Ebang Pharmaceutical is a comprehensive Chinese pharmaceutical enterprise specializing in the research, development, production, and commercialization of chemical drug preparations and Active Pharmaceutical Ingredients (APIs). Founded in 2003 and based in Zhuhai, the company has established a significant market presence in the fields of anti-infectives, cardiovascular treatments, and digestive system medications. Its core product portfolio features a wide range of cephalosporin antibiotics, including Cefazolin Sodium and Cefuroxime Sodium, alongside specialty treatments like Ozagrel Sodium for stroke management. Ebang operates multiple GMP-certified production lines and is vertically integrated, maintaining control over the quality of both its bulk drugs and finished dosage forms. The company continues to expand its pipeline through its dedicated research institute, focusing on high-end generics and improved formulations for the domestic Chinese market.